Clearmind Medicine, Inc. (CMND)
1.24
+0.07
(+5.98%)
USD |
NASDAQ |
Apr 07, 16:00
1.23
-0.01
(-0.81%)
After-Hours: 20:00
Clearmind Medicine EPS Diluted (Quarterly) : -3.317 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tilray Brands, Inc. | -0.2358 |
| Psyence Biomedical Ltd. | 0.00 |
| Achieve Life Sciences, Inc. | -0.2752 |
| Oncolytics Biotech, Inc. | -0.0139 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.855M |
| Total Expenses (Quarterly) | 3.855M |
| Enterprise Value | -7.749M |
| Earnings Yield | -1.39K% |
| Normalized Earnings Yield | -1684.32 |